NR3C1 and leukemia: Glucocorticoid receptor (NR3C1) signaling, activated by dexamethasone, a known treatment for leukemia, was found to be negligible change, aligning with the observed negative control of genes regulated by dexamethasone in EF-24–treated HL-60 cells [75].